These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21473713)

  • 21. Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain.
    Fortuny J; Kogevinas M; Garcia-Closas M; Real FX; Tardón A; Garcia-Closas R; Serra C; Carrato A; Lloreta J; Rothman N; Villanueva C; Dosemeci M; Malats N; Silverman D
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1696-702. PubMed ID: 16985032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic review: ibuprofen-induced liver injury.
    Zoubek ME; Lucena MI; Andrade RJ; Stephens C
    Aliment Pharmacol Ther; 2020 Mar; 51(6):603-611. PubMed ID: 31984540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury.
    Monteiro TP; El-Jaick KB; Jeovanio-Silva AL; Brasil PE; Costa MJ; Rolla VC; de Castro L
    J Clin Pharm Ther; 2012 Dec; 37(6):712-8. PubMed ID: 22845549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP2C9 polymorphisms: considerations in NSAID therapy.
    Ali ZK; Kim RJ; Ysla FM
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):108-14. PubMed ID: 19152219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Old and new antirheumatic drugs and the risk of hepatotoxicity.
    Anelli MG; Scioscia C; Grattagliano I; Lapadula G
    Ther Drug Monit; 2012 Dec; 34(6):622-8. PubMed ID: 23128910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-induced liver injury due to antimicrobials, central nervous system agents, and nonsteroidal anti-inflammatory drugs.
    Devarbhavi H; Andrade RJ
    Semin Liver Dis; 2014 May; 34(2):145-61. PubMed ID: 24879980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
    Singla N; Gupta D; Birbian N; Singh J
    Tuberculosis (Edinb); 2014 May; 94(3):293-8. PubMed ID: 24637014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsteroidal anti-inflammatory drugs exposure and the central nervous system.
    Auriel E; Regev K; Korczyn AD
    Handb Clin Neurol; 2014; 119():577-84. PubMed ID: 24365321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP2C9 polymorphism in non-steroidal anti-inflammatory drugs-induced gastropathy.
    Ma J; Yang XY; Qiao L; Liang LQ; Chen MH
    J Dig Dis; 2008 May; 9(2):79-83. PubMed ID: 18419640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antituberculosis drug-induced hepatitis: risk factors, prevention and management.
    Hussain Z; Kar P; Husain SA
    Indian J Exp Biol; 2003 Nov; 41(11):1226-32. PubMed ID: 15332488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bendazac hepatotoxicity: analysis of 16 cases].
    Prieto de Paula JM; Rodríguez Rodríguez E; Villamandos Nicás V; Sanz de la Fuente H; Prada Mínguez A; del Portillo Rubí A
    Rev Clin Esp; 1995 Jun; 195(6):387-9. PubMed ID: 7644786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin-induced peptic ulcer and genetic polymorphisms.
    Shiotani A; Sakakibara T; Nomura M; Yamanaka Y; Nishi R; Imamura H; Tarumi K; Kamada T; Hata J; Haruma K
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S31-4. PubMed ID: 20586862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug- and herb-induced liver injury: a case series from a single center.
    Dağ MS; Aydınlı M; Oztürk ZA; Türkbeyler IH; Koruk I; Savaş MC; Koruk M; Kadayıfçı A
    Turk J Gastroenterol; 2014 Feb; 25(1):41-5. PubMed ID: 24918129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative cross-omics analysis in primary mouse hepatocytes unravels mechanisms of cyclosporin A-induced hepatotoxicity.
    Van den Hof WF; Van Summeren A; Lommen A; Coonen ML; Brauers K; van Herwijnen M; Wodzig WK; Kleinjans JC
    Toxicology; 2014 Oct; 324():18-26. PubMed ID: 25047351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico models for drug-induced liver injury--current status.
    Przybylak KR; Cronin MT
    Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):201-17. PubMed ID: 22248266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema.
    Kowalski ML; Woessner K; Sanak M
    J Allergy Clin Immunol; 2015 Aug; 136(2):245-51. PubMed ID: 26254051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonsteroidal anti-inflammatory drug gastropathy at the new millennium: mechanisms and prevention.
    Rich M; Scheiman JM
    Semin Arthritis Rheum; 2000 Dec; 30(3):167-79. PubMed ID: 11124281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatotoxicity of antirheumatic drugs.
    Tolman KG
    J Rheumatol Suppl; 1990 May; 22():6-11. PubMed ID: 2192059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury.
    Lucena MI; Andrade RJ; Martínez C; Ulzurrun E; García-Martín E; Borraz Y; Fernández MC; Romero-Gomez M; Castiella A; Planas R; Costa J; Anzola S; Agúndez JA;
    Hepatology; 2008 Aug; 48(2):588-96. PubMed ID: 18666253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid therapy for a case of severe drug-induced cholestasis.
    Giannattasio A; D'Ambrosi M; Volpicelli M; Iorio R
    Ann Pharmacother; 2006 Jun; 40(6):1196-9. PubMed ID: 16720710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.